Gilead Sciences reported that in a recent Phase 2 study, its oral drug idelalisib successfully drove the life-threatening chronic lymphocytic leukemia (CLL) into remission.

http://www.allfordrugs.com/2013/05/29/gilead-sciences-reported-that-in-a-recent-phase-2-study-its-oral-drug-idelalisib-successfully-drove-the-life-threatening-chronic-lymphocytic-leukemia-cll-into-remission/
Gilead Sciences reported that in a recent Phase 2 study, its oral drug idelalisib successfully drove the life-threatening chronic lymphocytic leukemia (CLL) into remission.